Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recognition of driver genes with potential prognostic implications in lung adenocarcinoma based on H3K79me2. | Comput Struct Biotechnol J | 2022 | 36249560 | PubTator, text mining | PubMed |
| Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment. | Life Sci Alliance | 2022 | 36241426 | PubTator, text mining | PubMed |
| Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency. | Cell Death Discov | 2022 | 36195608 | PubTator, text mining | PubMed |
| Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics. | Nat Commun | 2022 | 36184661 | PubTator, text mining | PubMed |
| The viral and inflammation hypothesis of epileptic seizures based on bioinformatic study of circulating miRNAs and peripheral whole-blood mRNAs of adult epilepsy patients. | Front Neurol | 2022 | 36172025 | PubTator, text mining | PubMed |
| Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19. | Oxid Med Cell Longev | 2022 | 36132227 | PubTator, text mining | PubMed |
| Harnessing the Therapeutic Potential of Exosomes: A Novel Strategy for Anticancer and Antiviral Therapy. | Biomed Res Int | 2022 | 36132081 | PubTator, text mining | PubMed |
| Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease. | Transl Neurosci | 2022 | 36117858 | PubTator, text mining | PubMed |
| An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia. | PLoS Comput Biol | 2022 | 36099249 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments. | Front Cardiovasc Med | 2022 | 36082126 | PubTator, text mining | PubMed |
| Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review. | Molecules | 2022 | 36080397 | PubTator, text mining | PubMed |
| Small-Molecule PROTACs for Cancer Immunotherapy. | Molecules | 2022 | 36080223 | PubTator, text mining | PubMed |
Association of Dietary Patterns with Metabolic Syndrome in Chinese Children and Adolescents Aged 7-17: The China National Nutrition and Health Surveillance of Children and Lactating Mothers in 2016-2017. | Nutrients | 2022 | 36079782 | PubTator, text mining | PubMed |
| Apoptosis evasion via long non-coding RNAs in colorectal cancer. | Cancer Cell Int | 2022 | 36076273 | PubTator, text mining | PubMed |
| High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer. | Nat Commun | 2022 | 36071033 | PubTator, text mining | PubMed |
| Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36060972 | PubTator, text mining | PubMed |
| Pathogenesis from Inflammation to Cancer in NASH-Derived HCC. | J Hepatocell Carcinoma | 2022 | 36051860 | PubTator, text mining | PubMed |
| Pattern recognition receptor ligand-induced differentiation of human transitional B cells. | PLoS One | 2022 | 36040923 | PubTator, text mining | PubMed |
| The Notion of Coopetition-Based Open-Innovation in Business Practices: A Model to Accelerate Firm Performance. | Front Psychol | 2022 | 36033056 | PubTator, text mining | PubMed |
| Impact of circumferential tumor location of mid to low rectal cancer on oncologic outcomes after preoperative chemoradiotherapy. | Ann Surg Treat Res | 2022 | 36017139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers?page=13